Ritholtz Wealth Management grew its stake in Albemarle Corporation (NYSE:ALB – Free Report) by 237.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,557 shares of the specialty chemicals company’s stock after purchasing an additional 9,535 shares during the period. Ritholtz Wealth Management’s holdings in Albemarle were worth $1,434,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of ALB. Jacobi Capital Management LLC lifted its position in Albemarle by 47.2% in the third quarter. Jacobi Capital Management LLC now owns 16,025 shares of the specialty chemicals company’s stock worth $1,695,000 after buying an additional 5,142 shares during the last quarter. Silver Grove Financial Group Inc. increased its position in Albemarle by 193.3% during the third quarter. Silver Grove Financial Group Inc. now owns 437 shares of the specialty chemicals company’s stock valued at $46,000 after acquiring an additional 288 shares during the last quarter. Keybank National Association OH increased its position in Albemarle by 4,773.2% during the third quarter. Keybank National Association OH now owns 268,268 shares of the specialty chemicals company’s stock valued at $28,377,000 after acquiring an additional 262,763 shares during the last quarter. Elevated Capital Advisors LLC increased its position in Albemarle by 9,000.0% during the third quarter. Elevated Capital Advisors LLC now owns 637 shares of the specialty chemicals company’s stock valued at $67,000 after acquiring an additional 630 shares during the last quarter. Finally, New York Life Investment Management LLC raised its stake in shares of Albemarle by 183.5% in the third quarter. New York Life Investment Management LLC now owns 86,394 shares of the specialty chemicals company’s stock valued at $9,139,000 after acquiring an additional 55,915 shares during the period. Hedge funds and other institutional investors own 92.87% of the company’s stock.
Albemarle Stock Performance
ALB stock opened at $93.62 on Monday. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.34 and a quick ratio of 1.57. The business has a 50-day moving average price of $103.61 and a 200 day moving average price of $145.56. The company has a market capitalization of $11.05 billion, a P/E ratio of 22.61, a PEG ratio of 0.59 and a beta of 1.34. Albemarle Corporation has a 1-year low of $89.77 and a 1-year high of $221.00.
Albemarle (NYSE:ALB – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The specialty chemicals company reported $2.58 earnings per share for the quarter, topping analysts’ consensus estimates of $2.53 by $0.05. Albemarle had a net margin of 10.40% and a return on equity of 14.91%. The company had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.52 billion. During the same period in the prior year, the firm earned ($0.19) earnings per share. The firm’s revenue for the quarter was up 18.8% compared to the same quarter last year. As a group, equities research analysts forecast that Albemarle Corporation will post 10.64 EPS for the current fiscal year.
Albemarle Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Friday, December 18th will be issued a $0.41 dividend. The ex-dividend date is Friday, December 18th. This represents a $1.64 annualized dividend and a dividend yield of 1.8%. Albemarle’s payout ratio is currently 39.61%.
Wall Street Analyst Weigh In
ALB has been the topic of several recent analyst reports. Bank of America reduced their target price on shares of Albemarle from $131.00 to $120.00 in a research note on Thursday. JPMorgan Chase & Co. dropped their price target on shares of Albemarle from $160.00 to $140.00 and set a “neutral” rating for the company in a research note on Tuesday, August 25th. Royal Bank Of Canada cut their price target on shares of Albemarle from $129.00 to $119.00 and set an “outperform” rating on the stock in a report on Friday, November 6th. Argus reduced their price objective on shares of Albemarle from $230.00 to $135.00 and set a “buy” rating on the stock in a research report on Wednesday, October 7th. Finally, Truist Financial reissued a “buy” rating and issued a $170.00 price objective (down from $185.00) on shares of Albemarle in a research note on Friday, November 6th. Fifteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $152.63.
Albemarle Company Profile
Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.
Featured Articles
- Five stocks we like better than Albemarle
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
